Tiantian Wei
Sichuan University
12 Papers
16 Citations
Tiantian Wei is an academic researcher from Sichuan University. The author has contributed to research in topics: Medicine & Acute kidney injury. The author has an hindex of 5, co-authored 10 publications.
Chat about Author
Papers
Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition.
Sibei Tao,Lingzhi Li,Ling Li,Yuan Liu,Qian Ren,Min Shi,Jing Liu,Jing Jiang,Huichao Ma,Zhuo Huang,Zijing Xia,Jing Pan,Tiantian Wei,Yan Wang,Peiyun Li,Tian Lan,Xi Tang,Xiaoxi Zeng,Song Lei,Huairong Tang,Liang Ma,Liang Ma,Ping Fu +22 more
TL;DR: Gut microbiota composition was explored to be related to the occurrence of biopsy-proven DN from DM, and DM could be distinguished from HC by detecting g_Prevotella_9 level in feces, while DN was different from DM by the variables of g_Escherichia-Shigella and g_ Prevotella-9, which potentially contributed to the physiopathological diagnosis ofDN from DM.
134
Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis.
Ling Li,Tiantian Wei,Shuyun Liu,Chengshi Wang,Meng Zhao,Yanhuan Feng,Liang Ma,Yanrong Lu,Ping Fu,Jingping Liu +9 more
TL;DR: C5 hyperactivation promotes DKD by activating STAT3 in GECs and impairing the gut‐kidney axis, suggesting that this hyperactivation is a potential target for the treatment of DKD.
49
Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy.
TL;DR: It is highlighted that activation of GPR120 in podocytes ameliorates renal inflammation and fibrosis to protect against DN.
33
The Effect of Serum Neutrophil Gelatinase-Associated Lipocalin on the Discontinuation of Continuous Renal Replacement Therapy in Critically Ill Patients with Acute Kidney Injury.
TL;DR: Serum NGAL was a significant factor for predicting successful CRRT discontinuation in nonseptic AKI patients, however, urine output, rather than serum NGAL, was asignificant predictor in septic AKi patients.
28
Hemofilter with Adsorptive Capacities: Case Report Series.
Ling Zhang,Gloria Kai Yan Tang,Songqiao Liu,Jing Cai,Wai Ming Chan,Yi Yang,Ping Chang,Tiantian Wei,Xinyu Liu,Qiang Yao,Minmin Wang,Mark R. Marshall +11 more
TL;DR: Based on the experience gathered from 4 cases, oXiris should be used early in the treatment of septic AKI patients as an adjuvant therapy with good infection source control and should not be used to delay or replace infection sources control.